Imbed Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Imbed Biosciences, Inc. - overview
Established
2012
Location
Middleton, WI, US
Primary Industry
Medical Devices & Equipment
About
Based in Wisconsin, US, and founded in 2012 by Nicholas L. Abbott, Charles J. Czuprynski, and Christopher J. Murphy, Imbed Biosciences, Inc.
, a. k. a. Imbed Biosciences operates as a medical device company that focuses on developing advanced devices for the treatment of burns, wounds, and soft-tissue repair.
In January 2024, Imbed Biosciences, Inc. raised USD 10 million in venture debt funding led by Niterra Corporation Limited, with participation from Pegasus Tech Ventures. Imbed Biosciences offers Microlyte® Matrix, an antimicrobial synthetic skin substitute for chronic wounds; Surgaflex™, an ultrathin antimicrobial polymer matrix for surgical wounds; and PelashieldAM™, a hydrophilic antimicrobial matrix designed for burn wounds. These products are designed to address the challenges associated with different types of wounds, providing management solutions for healthcare providers.
The company plans to use its proceeds from January 2024 funding for growth strategy, strengthening its market presence, and product development.
Current Investors
WISC Partners, WARF Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies, Surgical Devices
Website
www.imbedbio.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.